September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
Impact of Medication Adherence on Diabetic Patients
Chronic illness treatment typically involves some level of long-term use of pharmacotherapy. While these medications may prove efficacious in contesting the disease, their full benefits often go unmet, because nearly 50% of patients do not to take the medications as prescribed.
Endocrine Society President Discusses Current State and Future of the Field
Like most medical fields endocrinology has seen changes in doctor recruitment, patient relationships, and overall care. The future of the field is discussed by the president of the Endocrine Society
Explaining the Link Between Diabetes, Anxiety, and Depression
March 11th 2015Researchers from Joslin Diabetes Center at Harvard Medical School may have uncovered an explanation for why patients with diabetes are more likely to develop anxiety and depression than patients with other chronic conditions requiring similar levels of management.
Weighing the Risks of Quitting Smoking and Obesity
One of the major concerns of people considering quitting smoking is whether they will gain weight. A new study has shown that may not need to be a concern and that the overall benefits to their health can outweigh the risks.
Improving the Safety of Diabetes Medications
As more diabetes drugs hit the market there are natural safety questions that come with these prescriptions. In recent years the US Food and Drug Administration has worked to increase the steps taken to ensure the safety of these drugs.
Bariatric Surgery Reduces Diabetes-Associated Vascular Disease in Obese Patients
March 6th 2015Bariatric surgery has been shown to reduce the long-term risk of diabetes-associated vascular disease in obese patients. According to study results presented at ENDO 2015, bariatric surgery reduced the risk of developing macrovascular events by 20% and reduced the risk of microvascular events by 50%.
Liraglutide Associated with Improved Glycemic Control in Overweight Patients with Prediabetes
March 6th 2015In overweight and obese individuals without diabetes, liraglutide 3.0 mg as an adjunct to diet and exercise was associated with greater reductions in fasting and postprandial glucose compared with diet and exercise alone.
Subspecialty Care and the Endocrinologist: Let's Get Virtual
March 3rd 2015Researchers from the Division of Endocrinology and Metabolism at the University of California, San Francisco analyzed the impact of virtual consultations on the spectrum and volume of endocrine consults. They measured access to endocrine care and downstream health care utilization. Their results indicate that virtual consultation offers many advantages for endocrinologists.
Mobilizing Immunotherapy for Type 1 Diabetes: On the Horizon
March 3rd 2015Type 1 diabetes mellitus is an autoimmune disease in which the body destroys all or part of its own roughly 1 billion β cells and cannot regenerate these critical endocrine components. Researchers have turned their attention to immunotherapies for treatment, postulating that targeting the immune system might restore β-cell function. It appears that combination therapies may be needed since clinical trial results have not met expectations based on animal studies.
The Use of Incretin-Based Therapy in Asian Patients with Diabetes
February 25th 2015Among the approximately 382 million people who have type 2 diabetes (T2DM) worldwide, approximately 20% live in South-East Asia and 65.1 million live in India. Asian populations are racially, demographically, culturally and socioeconomically heterogeneous. Researchers have identified unique trends in Asians diagnosed with T2DM.
Lipodystrophy: What HAART Has Taught Us
February 25th 2015The most common causes of lipodystrophy are insulin injection, antiretroviral drugs, and hereditary disorders. Some patients with insulin-related lipodystrophy also develop metabolic dysfunction, including insulin resistance, elevated free fatty acids level, abnormal adipocytokine secretion, and ectopic fat deposition.